Emily Blodget
Expertise in
11
conditions

Dr. Emily Blodget

Infectious Disease
101 The City Drive South, Building 30, 
Orange, CA 
Offers Telehealth
Expertise in
11
conditions
101 The City Drive South, Building 30, 
Orange, CA 

Overview

Dr. Emily Blodget is a board-certified UCI Health specialist in infectious diseases. Her clinical interests include HIV and AIDs, transplant infections and infectious diseases.She earned her medical degree from University College Cork School of Medicine in Cork, Ireland. She completed a residency in internal medicine at the Icahn School of Medicine at Mount Sinai in New York City, following by a fellowship in infectious disease from Los Angeles County-USC Medical Center. She comes to UCI Health and the UCI School of Medicine from the Keck School of Medicine at USC.Blodget's research interests include studying vancomycin-resistant enterococcus (VRE) infection in patients with cirrhosis who are awaiting liver transplantation. She is the author or co-author of numerous papers in peer-reviewed journals.She sees patients inOrange.

Dr. Blodget is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Cryptococcosis, Hepatitis, Coccidioidomycosis, and ECHO Virus.

Dr. Blodget is board certified in American Board Of Internal Medicine - Infectious Disease and American Board Of Internal Medicine - Internal Medicine. She is actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 1 clinical trial.

Specialties

Infectious Disease

Licenses

Internal Medicine in CA

Board Certifications

American Board Of Internal Medicine - Infectious Disease
American Board Of Internal Medicine - Internal Medicine

Fellowships

LAC/USC Infectious Diseases Fellowship Program - Infectious Diseases

Hospital Affiliations

Uci Health-Orange

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Inland Empire Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

UC Irvine Medical Center
101 The City Drive South, Building 30, Orange, CA 92868

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 3

24 Total Publications

Rapid HHV-6 Clearance Following Preemptive Short-Course Foscarnet in Allogeneic Stem Cell Transplant Recipients.
Rapid HHV-6 Clearance Following Preemptive Short-Course Foscarnet in Allogeneic Stem Cell Transplant Recipients.
Journal: American journal of hematology
Published: February 15, 2026
Similar Doctors
Expertise in
12
conditions
Dr. James A. Mckinnell
Infectious Disease
Expertise in
12
conditions
Dr. James A. Mckinnell
Infectious Disease
Referral may be required

Torrance Health Association Inc.

2841 Lomita Blvd, 
Torrance, CA 
 (25.7 miles away)
310-784-6954
Languages Spoken:
English
See accepted insurances
Offers Telehealth

James Mckinnell is an Infectious Disease provider practicing medicine in Torrance, California. Dr. Mckinnell is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Methicillin-Resistant Staphylococcus Aureus (MRSA), COVID-19, Sepsis, and Multisystem Inflammatory Syndrome in Children (MIS-C). Dr. Mckinnell is board certified in American Board Of Internal Medicine.

Expertise in
35
conditions
Dr. Jean-pierre E. Antaki
Infectious Disease
Expertise in
35
conditions
Dr. Jean-pierre E. Antaki
Infectious Disease
Referral may be required
Before you request

Antaki And Associates

801 S Chevy Chase Dr, Ste 101, 
Glendale, CA 
 (31.3 miles away)
818-242-5299
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

I seek to provide the most complete care to my patients in a caring and respectful way. Dr. Antaki is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Pneumonia, Hospital-Acquired Pneumonia, Sepsis, and COVID-19. Dr. Antaki is board certified in Internal Medicine (Sub: Infectious Disease) and American Board Of Internal Medicine. Dr. Antaki is currently accepting new patients.

Expertise in
2
conditions
Dr. Susan S. Huang
Infectious Disease
Expertise in
2
conditions
Dr. Susan S. Huang
Infectious Disease
Referral may be required

UC Irvine Medical Center

101 The City Drive South, Building 29, 
Orange, CA 
 (0.1 miles away)
714-456-7720
Languages Spoken:
English

Dr. Susan S. Huang is medical director of Epidemiology and Infection Prevention for UCI Health. Dr. Huang is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Hip Replacement. Dr. Huang is board certified in American Board Of Internal Medicine - Infectious Disease.

Frequently Asked Questions about Dr. Emily Blodget

How do I make an appointment with Dr. Emily Blodget?

You can book an appointment with Dr. Emily Blodget by calling their office at 714-456-7720. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Emily Blodget a top-rated expert for Cryptococcosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Emily Blodget is classified as an Distinguished expert for Cryptococcosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Emily Blodget specialize in?

While Dr. Emily Blodget is a Infectious Disease, they have specific expertise in Cryptococcosis, Hepatitis, and Coccidioidomycosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Dr. Emily Blodget participate in research or clinical trials?

Yes. Dr. Emily Blodget has published 24 articles and abstracts on conditions like Cryptococcosis. You can view a list of Dr. Emily Blodget's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Emily Blodget accept my insurance?

Dr. Emily Blodget accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 714-456-7720 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Blodget's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 29 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile